ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
103,211.53
-0.88%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. Ampio Pharmaceuticals Inc (CE) (AMPE) 시세

Ampio Pharmaceuticals Inc (CE)

Ampio Pharmaceuticals Inc (CE) (AMPE)

Amper SA
Amper SA
Amper SA
Amper SA
0.0026
0.00
(0.00%)
마감 18 1월 6:00AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
0.0026
매수가
0.00
매도가
0.00
거래량
4
0.00 일간 변동폭 0.00
0.000001 52주 범위 0.56
market_cap
2.952k
전일 종가
0.0026
개장가
-
최근 거래 시간
3
@
0.0026
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
2,315
발행 주식
1,135,358
배당수익률
-
주가수익률
0.00
주당순이익(EPS)
-7.6
매출
-
순이익
-8.63M

Ampio Pharmaceuticals Inc (CE) 정보

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"... Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.ampiopharma.com
본부
Wilmington, Delaware, USA
설립됨
-
Ampio Pharmaceuticals Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker AMPE. The last closing price for Ampio Pharmaceuticals (CE) was US$0. Over the last year, Ampio Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.56.

Ampio Pharmaceuticals (CE) currently has 1,135,358 shares in issue. The market capitalisation of Ampio Pharmaceuticals (CE) is US$2,951.93 . Ampio Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

AMPE 최신 뉴스

추가 뉴스

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering PR Newswire GREENWOOD VILLAGE, Colo., April 21, 2014 GREENWOOD VILLAGE, Colo., April 21, 2014...

21 4월 2014
PR Newswire (US)

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market

Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market PR Newswire GREENWOOD VILLAGE, Colo., May 17, 2011 GREENWOOD VILLAGE, Colo., May 17, 2011 /PRNewswire/ -- Ampio...

18 5월 2011
PR Newswire (US)

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement

Ampio Pharmaceuticals, Inc. Announces Final Closing of Private Placement and Filing of Resale Registration Statement PR Newswire GREENWOOD VILLAGE, Colo., April 19, 2011 GREENWOOD VILLAGE, Colo...

20 4월 2011
PR Newswire (US)

Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011

Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011 PR Newswire GREENWOOD VILLAGE, Colo., April 1, 2011 GREENWOOD VILLAGE, Colo., April...

01 4월 2011
PR Newswire (US)

CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc.

CORRECTED: Ampio Pharmaceuticals Announces Completion of Negotiations for Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., Aug. 3 GREENWOOD VILLAGE, Colo., Aug. 3...

04 8월 2010
PR Newswire (US)

Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc.

Ampio Pharmaceuticals, Inc. Announces Acquisition of DMI BioSciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., July 27 GREENWOOD VILLAGE, Colo., July 27 /PRNewswire-FirstCall/ -- Ampio...

27 7월 2010
PR Newswire (US)

Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™

Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™ PR Newswire GREENWOOD VILLAGE, Colo., July 21 GREENWOOD VILLAGE, Colo., July 21 /PRNewswire-FirstCall/ -- Ampio...

22 7월 2010
PR Newswire (US)

Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer

Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer PR Newswire GREENWOOD VILLAGE, Colo., May 10 GREENWOOD VILLAGE, Colo., May 10 /PRNewswire-FirstCall/ -- Ampio...

10 5월 2010
PR Newswire (US)

Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.

Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc. PR Newswire GREENWOOD VILLAGE, Colo., April 22 GREENWOOD VILLAGE, Colo., April 22 /PRNewswire-FirstCall/ -- Ampio Pharmaceuticals, Inc. (OTC...

22 4월 2010
PR Newswire (US)

Ampio Pharmaceuticals, Inc. Appoints New Independent Director

Ampio Pharmaceuticals, Inc. Appoints New Independent Director PR Newswire GREENWOOD VILLAGE, Colo., April 14 GREENWOOD VILLAGE, Colo., April 14 /PRNewswire-FirstCall/ -- Ampio Pharmaceuticals...

15 4월 2010
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1000.00260.00260.00261550.0026CS
4000.00260.08610.000531840.00420101CS
120.000418.18181818180.00220.08610.000523150.00521984CS
26-0.0374-93.50.040.08611.0E-621110.00453077CS
52-0.1474-98.26666666670.150.561.0E-641750.18556122CS
156-2.7474-99.90545454552.752.751.0E-67295200.02430019CS
260-0.0029-52.72727272730.00552.751.0E-67122530.02430019CS

AMPE - Frequently Asked Questions (FAQ)

What is the current Ampio Pharmaceuticals (CE) share price?
The current share price of Ampio Pharmaceuticals (CE) is US$ 0.0026
How many Ampio Pharmaceuticals (CE) shares are in issue?
Ampio Pharmaceuticals (CE) has 1,135,358 shares in issue
What is the market cap of Ampio Pharmaceuticals (CE)?
The market capitalisation of Ampio Pharmaceuticals (CE) is USD 2.95k
What is the 1 year trading range for Ampio Pharmaceuticals (CE) share price?
Ampio Pharmaceuticals (CE) has traded in the range of US$ 0.000001 to US$ 0.56 during the past year
What is the reporting currency for Ampio Pharmaceuticals (CE)?
Ampio Pharmaceuticals (CE) reports financial results in USD
What is the latest annual profit for Ampio Pharmaceuticals (CE)?
The latest annual profit of Ampio Pharmaceuticals (CE) is USD -8.63M
What is the registered address of Ampio Pharmaceuticals (CE)?
The registered address for Ampio Pharmaceuticals (CE) is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Ampio Pharmaceuticals (CE) website address?
The website address for Ampio Pharmaceuticals (CE) is www.ampiopharma.com
Which industry sector does Ampio Pharmaceuticals (CE) operate in?
Ampio Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TMGIMarquie Group Inc (PK)
US$ 0.0002
(19,900.00%)
4.03M
SEANSAEAN Group Inc (PK)
US$ 1.87
(18,600.00%)
100
ZPASZoompass Holdings Inc (CE)
US$ 0.0001
(9,900.00%)
675
GMPRGourmet Provisions International Corporation (PK)
US$ 0.0001
(9,900.00%)
35.31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.0001
(9,900.00%)
18.06M
STNXStartronix International Inc (CE)
US$ 0.000001
(-99.99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0.000001
(-99.97%)
2.03k
ISOLImage Software Inc (CE)
US$ 0.000001
(-99.91%)
59.2k
NBIONascent Biotech Inc (CE)
US$ 0.0002
(-99.55%)
8.7k
FHBCFernhill Beverage Inc (CE)
US$ 0.000001
(-99.24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0.0001
(0.00%)
349.77M
VTXBVortex Brands Company (PK)
US$ 0.0002
(0.00%)
297.52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0.0002
(0.00%)
233.53M
PHILPHI Group Inc (PK)
US$ 0.0002
(-33.33%)
184.12M
HMBLHUMBL Inc (PK)
US$ 0.0009
(-5.26%)
179.2M

토론

전체 피드 보기
maximus_art maximus_art 3 분 전
$VAPE Rarely do you get a product that is this good for humanity, and you get to buy it and trade it on the stock market.
This Transdermal GFR will be a huge step forward for nephrology and CKD (Chronic Kidney Disease) patients.
This is extra DD for those who want more information. T
VAPE
jeunke22 jeunke22 7 분 전
Biden announces a plan to supercharge American AI — with strings attached (Latitude Media)
In his final days in office, President Joe Biden is laying the groundwork for an unprecedented expansion of America’s artificial intelligence infrastructure, complicating President-elect Trump’s own amb
LWLG
MR, MR, 7 분 전
You keep saying BELOW average. "1.2 million shares Below avg." is what you have been saying.
MONI
Killmaril Killmaril 9 분 전
Hello, will I still have time to buy on Monday... Or will it be a rocket...?
AEHL
slb5150 slb5150 10 분 전
Me! 29K shares
AKEMF
Guido2 Guido2 17 분 전
https://x.com/guidoperei/status/1880534098516799939?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ


https://x.com/theyuckyone/status/1880352581324853630?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
beurstips beurstips 18 분 전
Totally agree..if you become CEO in a multinational with over 1000 employees you need 6 months( even 1 year) to know divisions,strategy, management,etcetera...but with 28 people...hahaha..after 1 month you know everybody and should have strategy..after 3 months you should have results....28 people.
SEV
GrantHorvat1 GrantHorvat1 20 분 전
You said it All.

Couldn't have said it better myself.
GVSI
GrantHorvat1 GrantHorvat1 21 분 전
Yes. Excellent. And you want to know the best thing?

There is absolutely NO DILUTION here as there is ZERO DEBT so there is none of the Big accumulation but no price appreciation that you see in many Otc stocks because of the share count being diluted so it never matters how much is
GVSI
jog49 jog49 22 분 전
"Pulte can be the interim director and later on confirmed."

I wish they would make Mel Watt interim director so we could see what he might be kissing with a Republican administration in charge.
FNMA
green maschine green maschine 23 분 전
It's about that time.
GCTK
ty3 ty3 32 분 전
Ya, a real company actually owns this !
GBHL
BasedOnFeels BasedOnFeels 42 분 전
Hey ILST management , if you want me to market/advertise old news articles here and X for some shares @ .001--- I am available as well.
ILST
fregata fregata 45 분 전
The best psychiatrist will not help you .game over you lost ,
FNMA
indepth05 indepth05 49 분 전
K's trades

400 shares @ 0.000025 @ 11:57 Yesterday
Total: ONE WHOLE Cent!
Gus Bus Strategy, Sell Low, Buy High...
LEHNQ
fdicr fdicr 53 분 전
FYI,

Trump hates those who short stocks.
FNMA
Moonboy1 Moonboy1 56 분 전
Shib has been in a bear market for 5 years now. And that absolutely has not changed. There is nothing but lower highs on the 5 yr chart. The pump to the 4s last March was just a lower high on the chart from its all time high. The pump to the 2s recently is nothing but another lower high on the chart
SHIBUSD
236T568 236T568 60 분 전
One year from today. Ha!

https://www.instagram.com/reel/DDGJICUyaqb/?igsh=MzRlODBiNWFlZA==
RuudSaltis RuudSaltis 1 시간 전
It’s clear that the new management is active, transparent (seen some mails to shareholders aswell!) and committed. Second time this calendar year somebody in the BOD can’t wait to exercise options!! Great believe in the company and a sign of insider trust!
LWLG
jog49 jog49 1 시간 전
"Monday it starts of at 7 and goes to 11. 7 ... Eleven baby.

$11 by monday"

Unfortunately, markets are closed Monday.
FNMA
DruidOracle55 DruidOracle55 1 시간 전
Proof?
MSTR
DruidOracle55 DruidOracle55 1 시간 전
Well, i have limited my farting and stopped breathing so it will all even out.
Do your part and stop breathing.
MSTR
StockItOut StockItOut 1 시간 전
Could have sworn I saw that Biza had provided funding for Xeriant in the past, yet a while back looking at Xeriant SEC filings I could not locate what I thought I had previously read. Some Note, or was it a JV, where the 'Biza Shares' were allocated or designated. Maybe it was American Aviation Tech
XERI
RSuave25020 RSuave25020 1 시간 전
If the bashers are the ones here on this website I am sure they,  are not the ones influencing the entire stock market's decision,  to buy and sell shares of LQMT. As well as the delays in the technology and the lack of sales of this product. 
        When the stock has been dragging the grou
LQMT

최근 히스토리

USOTC
AMPE
Ampio Pharmaceuticals (CE)
TG
QAA
Quanta Svcs Dl 00001
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유